How severe is CVE-2015-3954?

CVE-2015-3954 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2015-3954 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 2% (79th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2015-3954?

CVE-2015-3954 primarily affects Pifzer Plum A+ Infusion System Firmware. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.

How do I fix CVE-2015-3954?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.

When was CVE-2015-3954 published?

CVE-2015-3954 was published on 2019-03-25 and last updated on 2026-06-17.

CVE-2015-3954

CVE-2015-3954 is a critical-severity vulnerability in Pifzer Plum A+ Infusion System Firmware with a CVSS 3.x base score of 9.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-285.

Key facts

Severity: Critical (CVSS 3.x base score 9.8)
CVSS v2: 10.0
EPSS exploit prediction: 2% (79th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-285
Affected product: Pifzer Plum A+ Infusion System Firmware
Published: 2019-03-25
Last modified: 2026-06-17

Description

Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior give unauthenticated users root privileges on Port 23/TELNET by default. An unauthorized user could issue commands to the pump. Hospira recommends that customers close Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.

Frequently asked questions

What is CVE-2015-3954?: Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior give unauthenticated users root privileges on Port 23/TELNET by default. An unauthorized user could issue commands to the pump. Hospira recommends that customers close Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.
How severe is CVE-2015-3954?: CVE-2015-3954 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2015-3954 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 2% (79th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2015-3954?: CVE-2015-3954 primarily affects Pifzer Plum A+ Infusion System Firmware. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2015-3954?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
When was CVE-2015-3954 published?: CVE-2015-3954 was published on 2019-03-25 and last updated on 2026-06-17.

References

https://ics-cert.us-cert.gov/advisories/ICSA-15-161-01

Affected products (3)

cpe:2.3:o:pifzer:plum_a\+_infusion_system_firmware:*:*:*:*:*:*:*:*
cpe:2.3:o:pifzer:plum_a\+3_infusion_system_firmware:*:*:*:*:*:*:*:*
cpe:2.3:o:pifzer:symbiq_infusion_system_firmware:*:*:*:*:*:*:*:*

More vulnerabilities in Pifzer Plum A+ Infusion System Firmware

CVE-2015-3956 — Critical (CVSS 9.8): Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq…
CVE-2015-3953 — Critical (CVSS 9.8): Hard-coded accounts may be used to access Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion…
CVE-2015-3952 — High (CVSS 7.5): Wireless keys are stored in plain text on Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion…

All CVEs affecting Pifzer Plum A+ Infusion System Firmware →

Other CWE-285 (Improper Authorization) vulnerabilities

CVE-2025-65041 — Critical (CVSS 10.0): Improper authorization in Microsoft Partner Center allows an unauthorized attacker to elevate privileges over a network.
CVE-2023-33189 — Critical (CVSS 10.0): Pomerium is an identity and context-aware access proxy. With specially crafted requests, incorrect authorization…
CVE-2022-2595 — Critical (CVSS 10.0): Improper Authorization in GitHub repository kromitgmbh/titra prior to 0.79.1.
CVE-2021-28799 — Critical (CVSS 10.0): An improper authorization vulnerability has been reported to affect QNAP NAS running HBS 3 (Hybrid Backup Sync. ) If…
CVE-2026-34048 — Critical (CVSS 9.9): Coolify is an open-source and self-hostable tool for managing servers, applications, and databases. Prior to…
CVE-2026-5412 — Critical (CVSS 9.9): In Juju versions prior to 2.9.57 and 3.6.21, an authorization issue exists in the Controller facade. An authenticated…

Browse all CWE-285 (Improper Authorization) vulnerabilities →